Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster lunch

2096 - Survival pattern of primary heart cancer (539P)


18 Nov 2017


Poster lunch


eman Ramadan


Annals of Oncology (2017) 28 (suppl_10): x166-x168. 10.1093/annonc/mdx677


E. Ramadan1, A. Meshref2

Author affiliations

  • 1 Cardiology, Zagazig General Hospital, 273301 - Zagazig/EG
  • 2 General Practitioner, Suez Canal University Hospital, 41522 - Ismailia/EG


Abstract 2096


Primary malignancy of the heart are one of the rare tumors. This study aimed to show factors that affecting the survival rate of those patient with primary heart malignancy.


All 18 SEER registries database was used to obtain data of patient who diagnosed with primary malignant heart tumors between 2000 – 2013. One-year relative survival rates was by Kaplan-Meir method. We compared relative survival rates among groups of patients according to different variables.


389 patients met the selection criteria in SEER database. The result showed that primary malignant heart tumors is most common in white race (75.6%), male gender (54.8%) and (40-79y) age group (62%). (>40 y) age group showed significant (P value =0.003) high one-year relative survival rate] 61% (51%-69.6%) [. Hemangiosarcoma (9120/3) was the most frequent histological type (29.3%). Although fibromyxosarcoma (8811/3) showed on of lowest frequent histological type, it shows high significant (P value =0.003) one-year relative survival rate] 83.8% (48.7%-95.7%) [. Overall comparison of different modalities of treatment showed insignificant difference (P value =0.094) of one-year relative survival rate. Although surgical intervention showed significant (P value > 0.001) increase in one-year relative survival rate] 67.1% (28.1%-88.2) [of moderately differentiated; Grade II cardiac cancer comparing with another treatment modalities. Also surgical intervention combined with radiotherapy showed significant (P value =0.007) increase in one year relative survival rate] 43% (14%-69.6%) [of poorly differentiated; Grade III cardiac cancer comparing with another treatment modalities].


Solitary surgical intervention modality of treatment is recommended in patient with grade II primary heart disease unlike combination of surgical intervention and radiotherapy with grad III of primary heart cancer which showed highest one-year survival rate.

Clinical trial identification

Legal entity responsible for the study

Eman Ramadan




All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.